Wu Nian, Huan Lu, Liu Hua, Wang Zhiwei, Yu Fucai
Department of Hepatobiliary and Pancreatic Surgery, Chongqing Fifth People's Hospital, Chongqing, China.
Department of Anesthesiology, Chongqing Fifth People's Hospital, Chongqing, China.
Medicine (Baltimore). 2025 Aug 29;104(35):e42512. doi: 10.1097/MD.0000000000042512.
necrotizing pancreatitis is a severe complication of acute pancreatitis, often requiring invasive interventions to manage its high mortality and morbidity. The optimal timing and type of invasive procedures remain uncertain, necessitating a systematic evaluation to guide clinical decision-making.
A systematic review and Bayesian network meta-analysis were conducted following the PRISMA guidelines. Relevant randomized controlled trials (RCTs) published up to November 2024 were retrieved from PubMed, EMBASE, and the Cochrane Library. The study assessed 10 invasive interventions, including early and delayed drainage, step-up approaches, and open surgeries, focusing on mortality and major complications. Statistical analysis employed random-effects models and Bayesian frameworks to synthesize direct and indirect evidence.
Fifteen RCTs involving 857 patients were included. Delayed step-up surgery (DSU) and early drainage (ED) with lavage (EDL) demonstrated significant survival benefits, with lower mortality rates and reduced complications. Conversely, delayed video-assisted surgery (DVS) was associated with the highest mortality. No statistically significant differences were observed between ED and EDL or ED and delayed drainage in direct comparisons. Subgroup analyses revealed no significant mortality difference between early and delayed interventions (OR = 1.15, 95% CI = 0.54-2.46), while EDL and DSU emerged as optimal strategies in early and delayed interventions, respectively.
This review and network meta-analysis suggests that DSU and EDL may be promising options for treating necrotizing pancreatitis, though current evidence is inconclusive. Given varying risks, especially with DVS, treatment should be tailored to individual cases. More high-quality RCTs are needed to strengthen the evidence and guide practice.
坏死性胰腺炎是急性胰腺炎的一种严重并发症,常常需要侵入性干预措施来应对其高死亡率和高发病率。侵入性手术的最佳时机和类型仍不确定,因此需要进行系统评估以指导临床决策。
按照PRISMA指南进行了系统评价和贝叶斯网络荟萃分析。从PubMed、EMBASE和Cochrane图书馆检索截至2024年11月发表的相关随机对照试验(RCT)。该研究评估了10种侵入性干预措施,包括早期和延迟引流、逐步升级方法以及开放手术,重点关注死亡率和主要并发症。统计分析采用随机效应模型和贝叶斯框架来综合直接和间接证据。
纳入了15项涉及857例患者的RCT。延迟逐步升级手术(DSU)和带灌洗的早期引流(EDL)显示出显著的生存益处,死亡率较低且并发症减少。相反,延迟电视辅助手术(DVS)与最高死亡率相关。在直接比较中,ED和EDL之间或ED和延迟引流之间未观察到统计学显著差异。亚组分析显示早期和延迟干预之间的死亡率无显著差异(OR = 1.15,95% CI = 0.54 - 2.46),而EDL和DSU分别在早期和延迟干预中成为最佳策略。
本综述和网络荟萃分析表明,DSU和EDL可能是治疗坏死性胰腺炎的有前景的选择,尽管目前的证据尚无定论。鉴于风险各异,尤其是DVS的风险,治疗应根据个体情况量身定制。需要更多高质量的RCT来加强证据并指导实践。